289 related articles for article (PubMed ID: 32213944)
1. Antagonists of Vitamin K-Popular Coumarin Drugs and New Synthetic and Natural Coumarin Derivatives.
Kasperkiewicz K; Ponczek MB; Owczarek J; Guga P; Budzisz E
Molecules; 2020 Mar; 25(6):. PubMed ID: 32213944
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 3-amino-4-hydroxy coumarin and dihydroxy-phenyl coumarins as novel anticoagulants.
Danis O; Yuce-Dursun B; Gunduz C; Ogan A; Sener G; Bulut M; Yarat A
Arzneimittelforschung; 2010; 60(10):617-20. PubMed ID: 21125812
[TBL] [Abstract][Full Text] [Related]
3. [Oral anticoagulation with vitamin K antagonists].
Alberio L
Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470
[TBL] [Abstract][Full Text] [Related]
4. [New insight in therapeutic anticoagulation by Coumarin derivatives].
Oldenburg J; Seidel H; Pötzsch B; Watzka M
Hamostaseologie; 2008 Feb; 28(1-2):44-50. PubMed ID: 18278162
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.
Ufer M
Clin Pharmacokinet; 2005; 44(12):1227-46. PubMed ID: 16372822
[TBL] [Abstract][Full Text] [Related]
6. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
van Leeuwen Y; Rosendaal FR; van der Meer FJ
Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver.
Hildebrandt EF; Suttie JW
Biochemistry; 1982 May; 21(10):2406-11. PubMed ID: 6807339
[TBL] [Abstract][Full Text] [Related]
8. Fever as a risk factor for increased response to vitamin K antagonists: a review of the evidence and potential mechanisms.
Self TH; Oliphant CS; Reaves AB; Richardson AM; Sands CW
Thromb Res; 2015 Jan; 135(1):5-8. PubMed ID: 25456000
[TBL] [Abstract][Full Text] [Related]
9. Oral anticoagulant drugs and the risk of osteoporosis: new anticoagulants better than old?
Tufano A; Coppola A; Contaldi P; Franchini M; Minno GD
Semin Thromb Hemost; 2015 Jun; 41(4):382-8. PubMed ID: 25703521
[TBL] [Abstract][Full Text] [Related]
10. An insight into the therapeutic applications of coumarin compounds and their mechanisms of action.
Garg SS; Gupta J; Sharma S; Sahu D
Eur J Pharm Sci; 2020 Sep; 152():105424. PubMed ID: 32534193
[TBL] [Abstract][Full Text] [Related]
11. The in vivo effects of acenocoumarol, phenprocoumon and warfarin on vitamin K epoxide reductase and vitamin K-dependent carboxylase in various tissues of the rat.
de Boer-van den Berg MA; Thijssen HH; Vermeer C
Biochim Biophys Acta; 1986 Oct; 884(1):150-7. PubMed ID: 3490277
[TBL] [Abstract][Full Text] [Related]
12. Vitamin K and coumarin anticoagulants: dependence of anticoagulant effect on inhibition of vitamin K transport.
Lowenthal J; Birnbaum H
Science; 1969 Apr; 164(3876):181-3. PubMed ID: 5774189
[TBL] [Abstract][Full Text] [Related]
13. [The interaction between drugs and oral anticoagulants of the coumarin group].
Verstraete M
Sem Hop; 1978 May; 54(13-16):505-8. PubMed ID: 211593
[TBL] [Abstract][Full Text] [Related]
14. Differential cellular effects of old and new oral anticoagulants: consequences to the genesis and progression of atherosclerosis.
Schurgers LJ; Spronk HM
Thromb Haemost; 2014 Nov; 112(5):909-17. PubMed ID: 25298033
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of ticrynafen potentiation of coumarin anticoagulant action.
Preusch PC; Suttie JW
Biochem Pharmacol; 1983 Aug; 32(16):2393-8. PubMed ID: 6615542
[TBL] [Abstract][Full Text] [Related]
16. Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin.
Rost S; Fregin A; Hünerberg M; Bevans CG; Müller CR; Oldenburg J
Thromb Haemost; 2005 Oct; 94(4):780-6. PubMed ID: 16270630
[TBL] [Abstract][Full Text] [Related]
17. [Oral anticoagulants and coumarin classes].
Kemkes-Matthes B; Barthels M
Hamostaseologie; 2004 Nov; 24(4):279-85. PubMed ID: 15526072
[TBL] [Abstract][Full Text] [Related]
18. [Resistance to coumarin derivatives due to mutated vitamin-K enzyme].
Hermans MH; Poodt J; van Geest-Daalderop JH; Péquériaux NC; Conemans JM
Ned Tijdschr Geneeskd; 2009; 153():A691. PubMed ID: 19857286
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Journey and Recent Advances in the Synthesis of Coumarin Derivatives.
Sinha S; Singh K; Ved A; Hasan SM; Mujeeb S
Mini Rev Med Chem; 2022; 22(9):1314-1330. PubMed ID: 34784861
[TBL] [Abstract][Full Text] [Related]
20. Vitamin K metabolism in a patient resistant to vitamin K antagonists.
Keréveur A; Leclercq M; Trossaërt M; Dupeyron JP; Parent F; Horellou MH; Conard J; Bachmann F; Samama MM
Haemostasis; 1997; 27(4):168-73. PubMed ID: 9483171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
